On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Medication-related osteoporosis: others

Atsushi Suzuki; Sahoko S.ekiguchi Ueda; Ayako Kakita

On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Medication-related osteoporosis: others

Atsushi Suzuki, Sahoko S.ekiguchi Ueda, Ayako Kakita

Department of Endocrinology, Diabetes and Metabolism

Research output: Contribution to journal › Article › peer-review

Abstract

Glucocorticoid and sex-steroid deprivation therapies are two major causes of medication-related osteoporosis. As clinical course of osteoporosis is rather chronic, other drugs for common chronic diseases could also affect the incidence of osteoporotic fracture. Peroxisome proliferator-activated receptor-γ agonist, loop diuretics, selective serotonin reuptake inhibitor, anticonvulsants and proton pump inhibitors are now considered to be important candidates as the cause of medication-related osteoporosis.

Original language	English
Pages (from-to)	1367-1372
Number of pages	6
Journal	Clinical calcium
Volume	25
Issue number	9
Publication status	Published - 01-09-2015

All Science Journal Classification (ASJC) codes

General Medicine

Cite this

@article{93d4f8643ee5474dbb9e1328b47ec9c9,

title = "On {"}2015 Guidelines for Prevention and Treatment of Osteoporosis{"}. Medication-related osteoporosis: others",

abstract = "Glucocorticoid and sex-steroid deprivation therapies are two major causes of medication-related osteoporosis. As clinical course of osteoporosis is rather chronic, other drugs for common chronic diseases could also affect the incidence of osteoporotic fracture. Peroxisome proliferator-activated receptor-γ agonist, loop diuretics, selective serotonin reuptake inhibitor, anticonvulsants and proton pump inhibitors are now considered to be important candidates as the cause of medication-related osteoporosis. ",

author = "Atsushi Suzuki and Ueda, {Sahoko S.ekiguchi} and Ayako Kakita",

year = "2015",

month = sep,

day = "1",

language = "English",

volume = "25",

pages = "1367--1372",

journal = "Clinical calcium",

issn = "0917-5857",

publisher = "Iyaku (Medicine & Drug) Journal Co",

number = "9",

}

TY - JOUR

T1 - On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Medication-related osteoporosis

T2 - others

AU - Suzuki, Atsushi

AU - Ueda, Sahoko S.ekiguchi

AU - Kakita, Ayako

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Glucocorticoid and sex-steroid deprivation therapies are two major causes of medication-related osteoporosis. As clinical course of osteoporosis is rather chronic, other drugs for common chronic diseases could also affect the incidence of osteoporotic fracture. Peroxisome proliferator-activated receptor-γ agonist, loop diuretics, selective serotonin reuptake inhibitor, anticonvulsants and proton pump inhibitors are now considered to be important candidates as the cause of medication-related osteoporosis.

AB - Glucocorticoid and sex-steroid deprivation therapies are two major causes of medication-related osteoporosis. As clinical course of osteoporosis is rather chronic, other drugs for common chronic diseases could also affect the incidence of osteoporotic fracture. Peroxisome proliferator-activated receptor-γ agonist, loop diuretics, selective serotonin reuptake inhibitor, anticonvulsants and proton pump inhibitors are now considered to be important candidates as the cause of medication-related osteoporosis.

UR - http://www.scopus.com/inward/record.url?scp=84952720251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952720251&partnerID=8YFLogxK

M3 - Article

C2 - 26320537

AN - SCOPUS:84952720251

SN - 0917-5857

VL - 25

SP - 1367

EP - 1372

JO - Clinical calcium

JF - Clinical calcium

IS - 9

ER -

On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Medication-related osteoporosis: others

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this